Congratulations to one of BaseLaunch’s portfolio companies, Polyneuron on their latest milestone: First clinical trial application approval. Wishing you great success with the studies later this year for validation of the Antibody-Catch.™

Download the press release here.

Share this article

View all news

Sign up to receive our newsletter in your inbox.